Pharmaco-economic evaluation ("cost-benefit" analysis) of gastroesophageal reflux treatment
Guseĭnzade, M.G.; Li, I.A.; Lazebnik, L.B.
Eksperimental'naia i Klinicheskaia Gastroenterologiia 5: 40-44
2003
ISSN/ISBN: 1682-8658 PMID: 14621609 Document Number: 559925
Document emailed within 1 workday
Related Documents
Wessels, F.; Anderson, A.N.; Kropman, K. 1999: The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. a cost-minimisation pharmaco-economic model South African Medical Journal 89(7 Part 2): 791-794Wessels, F.; Anderson, A.N.; Ebrahim, O. 1998: Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. a pharmaco-economic study based on a meta-analysis South African Medical Journal 88(3): 251-255
Habu, Y.; Yoshino, T.; Shio, S.; Hayakumo, T.; Kawai, K. 2004: Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 62(8): 1504-1509
Mei, J.; Yu, Y.; Ma, J.; Yu, X. 2016: Evaluation of the effectiveness of esomeprazole treatment strategies in the management of patients with gastroesophageal reflux disease symptoms: a meta-analysis Die Pharmazie 71(5): 285-291
Zhong, Y.; Wu, X. 2020: Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects Plos one 15(3): E0229739
Duff, P.; Dolphin, C. 2007: Cost-benefit analysis of assistive technology to support independence for people with dementia – Part 2: Results from employing the ENABLE cost-benefit model in practice Technology and Disability 19(2-3): 79-90
Merritt, T.A.; Hallman, M.; Vaucher, Y.; McFeeley, E.; Tubman, T.R. 1990: Impact of surfactant treatment on cost of neonatal intensive care: a cost-benefit analysis Journal of Perinatology: Official Journal of the California Perinatal Association 10(4): 416-419
Danzig, J.; Navarro, R.; Inami, D.; Morreale, A.; Tokayer, A.; Wong, W.; Compton, J.; Page, R.N.; Sweet, F.B. 2001: The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion Managed Care Interface Suppl B: 13-20; Discussion 24-7 31-3
Semenikhin, V.A.; Petrov, A.G.; Petro, G.P. 2015: Methodic approaches to pharmaco-economic evaluation of vibration disease inpatient treatment in miners Meditsina Truda i Promyshlennaia Ekologiia 5: 29-34
Enríquez Zarabozo, E.; Moreno Hurtado, C.; Blesa Sánchez, E.; Vargas Muñoz, I.; Amat Valero, S.; Ayuso Velasco, R. 2011: Gastroesophageal reflux disease. Evaluation and indication for surgical treatment by esophageal phmetry Cirugia Pediatrica: Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica 24(2): 93-97
Shiino, Y.; Filipi, C.J.; Tomonaga, T.; Awad, Z.T.; Marsh, R.E. 2000: Does the duration of gastroesophageal reflux disease and degree of acid reflux correlate with esophageal function? A retrospective analysis of 768 patients Journal of Clinical Gastroenterology 30(1): 56-60
Vasil'ev, I.V.; Noskova, K.K.; Zelenikin, S.A. 2002: Effectiveness of pariet (rabeprazole) in the treatment of gastroesophageal reflux disease (at the reflux-esophagitis stage) Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 55-60; 190
Arj-ong, S.; Chotivitayatarakorn, P.; Lertsapcharoen, P.; Khongphatthanayothin, A.; Thisyakorn, C. 2003: A cost-benefit analysis of intravenous immunoglobulin treatment in children with Kawasaki disease Journal of the Medical Association of Thailand 86(Suppl): S179-S188
Larkö, O.; Swanbeck, G. 1982: Psoriasis treatment and a day-care centre: clinical aspects and an attempt at a cost-benefit analysis Acta Dermato-Venereologica 62(5): 413-418
Deirdre Wulf 1981: Cost-Benefit and Cost-Effectiveness Analysis for Family Planning Programs International Family Planning Perspectives 7(4): 141-144
Turajane, T.; Chaweevanakorn, U.; Sungkhun, P.; Larbphiboonpong, V.; Wongbunnak, R. 2012: Cost-utility analysis and economic burden of knee osteoarthritis treatment: the analysis from the real clinical practice Journal of the Medical Association of Thailand 95(Suppl 10): S98-104
Skrbo, A.; Sober, M.; Skrbo, S.; Omerhodzić, A.; Zunić, L. 2005: Pharmaco-economic analysis of NSAID usage in Gastroenterology Department of Tuzla Clinic Medicinski arhiv 59(5): 317-320
Fuller, J.F. 1974: Cost-benefit and cost-effectiveness analysis New Zealand Dental Journal 70(322): 282-288
Uribe, P.; Csendes, A.; Larrain, A.; Strauszer, T.; Ayala, M. 1973: Evaluation of surgery of pathological gastroesophageal reflux Revista Medica de Chile 101(2): 125-128
Szaflarska-Popławska, A.; Popławski, C.; Mierzwa, G. 2007: Impedance-pH analysis in gastroesophageal reflux monitoring Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(136): 302-306